Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

12.49
-0.1600-1.26%
Volume:130.16K
Turnover:1.59M
Market Cap:344.18M
PE:-0.57
High:12.69
Open:12.65
Low:11.86
Close:12.65
52wk High:29.06
52wk Low:8.72
Shares:27.56M
Float Shares:10.87M
Volume Ratio:0.53
T/O Rate:1.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-21.9706
EPS(LYR):-3.3635
ROE:-182.66%
ROA:-73.99%
PB:4.74
PE(LYR):-3.71

Loading ...

Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 14, 2026

Correspondence

Form CORRESP - Correspondence
Jan 07, 2026

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 04, 2025

Major Issues Report

Form 8-K - Current report
Nov 06, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Jul 31, 2025

Major Issues Report

Form 8-K - Current report
Jul 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 19, 2025

Major Issues Report

Form 8-K - Current report
Jun 06, 2025

Major Issues Report

Form 8-K - Current report
May 30, 2025

Major Issues Report

Form 8-K - Current report
May 30, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 29, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025

Correspondence

Form CORRESP - Correspondence
May 12, 2025

Correspondence

Form CORRESP - Correspondence
Apr 29, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations